Completed
CTN 047: AZT, ddI, ddC
Combination Therapy for Advanced HIV Disease: A Community-based Randomized Trial of the Safety and Laboratory Effects of ZDV/ddI vs ZDV/ddC
Learn MoreCompleted
Combination Therapy for Advanced HIV Disease: A Community-based Randomized Trial of the Safety and Laboratory Effects of ZDV/ddI vs ZDV/ddC
Learn MoreCompleted
Evaluation of SQ32,756 (BV ara U) Versus Acyclovir in the Treatment of Localized Herpes Zoster in HIV Infected Patients
Learn MoreCompleted
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
Learn MoreCompleted
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
Learn MoreCompleted
Rifabutin Therapy for the Prevention of MAC in Patients with AIDS
Learn MoreCompleted
Clinical Evaluation of Itraconazole vs. Ketoconazole in HIV+ Patients with Oropharyngeal and/or Oesophageal Candidiasis
Learn MoreCompleted
A Pilot Controlled Double Blind Study of Acemennan in Patients Receiving AZT for the Treatment of Advanced HIV Disease
Learn MoreCompleted
Phase III Study of AZT with Two Dose Levels of Intron-A in Treatment of AIDS-Related Kaposi's Sarcoma
Learn MoreCompleted
A Prospective, Randomized Comparative Trial of Combination Chemotherapy of MAC Infection in AIDS: Trial results
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.